Loading
Led GAP70+, which showed a geriatric assessment cuts serious chemotherapy toxicity in older patients.
Supriya Mohile was principal investigator of GAP70+, the cluster-randomised trial showing that giving oncologists a geriatric assessment with management recommendations reduces grade 3-5 toxicity in older adults with advanced cancer without compromising survival, and led the ASCO guideline recommending geriatric assessment for all patients over 65 receiving chemotherapy. She directs geriatric oncology research at Wilmot.
Shares GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.
Shares GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.
Shares GAP70+: a geriatric assessment before chemotherapy cut serious toxicity in older adults by a fifth, Geriatric assessment.
Shares Geriatric assessment and the tag supportive-care.